Find out more about Dane Cheasley's experience
Dane Cheasley's highlights
Dane Cheasley's selected work
High Throughput Discovery Of Synergistic Drug Combinations For Patients With Low-Grade Ser..
A Refined Cut-Off for p53 Immunohistochemistry Improves Prediction of TP53 Mutation Status..
Improving Early Detection And Management Of Women At Risk Of Developing Interval Breast Ca..
Displaying the 2 most recent projects by Dane Cheasley.
Displaying the 21 most recent scholarly works by Dane Cheasley.
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
Tanjina Kader, Kenneth Elder, Magnus Zethoven, Timothy Semple, Prue Hill, David L Goode, Niko Thio, Dane Cheasley, Simone M Rowley, David J Byrne, Jia-Min Pang, Islam M Miligy, Andrew R Green, Emad A Rakha, Stephen B Fox, G Bruce Mann, Ian G Campbell, Kylie L Gorringe
Journal article | 2020 | npj Breast Cancer
Intraductal papillomas (IDP) are challenging breast findings because of their variable risk of progression to malignancy. The mole..
A Refined Cut-Off for p53 Immunohistochemistry Improves Prediction of TP53 Mutation Status in Ovarian Mucinous Tumors: Implications for Outcome Analyses
Eun-Young Kang, Dane Cheasley, Cecile Le Page, Matthew Wakefield, Yoland Antill, Kylie Gorringe, Martin Kobel
Conference Proceedings | 2020 | Modern Pathology
Therapeutic options for mucinous ovarian carcinoma
Kylie L Gorringe, Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, David DL Bowtell, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Sian Fereday, C Blake Gilks, Charlie Gourley, Alison M Hadley, Joy Hendley, Sally M Hunter, Scott H Kaufmann, et al.
Journal article | 2020 | Gynecologic Oncology
OBJECTIVE: Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype that responds poorly to conventional chemother..
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer
Na Li, Simone McInerny, Magnus Zethoven, Dane Cheasley, Belle WX Lim, Simone M Rowley, Lisa Devereux, Norah Grewal, Somayeh Ahmadloo, David Byrne, Jue Er Amanda Lee, Jason Li, Stephen B Fox, Thomas John, Yoland Antill, Kylie L Gorringe, Paul A James, Ian G Campbell
Journal article | 2019 | JNCI: Journal of the National Cancer Institute
BACKGROUND: Loss-of-function variants in RAD51C are associated with familial ovarian cancer, but its role in hereditary breast can..
Integration of tumour sequencing and case-control analyses is a powerful tool for identification of cancer predisposition genes
I Campbell, N Li, B Lim, S McInerny, M Zethoven, D Cheasley, S Rowley, L Devereux, A Lee, N Grewal, P James
Conference Proceedings | 2019 | EUROPEAN JOURNAL OF HUMAN GENETICS
The molecular origin and taxonomy of mucinous ovarian carcinoma
Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, Michael S Anglesio, George Au-Yeung, Maret Bohm, David Dl Bowtell, Alison Brand, Georgia Chenevix-Trench, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Renee Demeo, Rhiannon Dudley, Nicole Fairweather, et al.
Journal article | 2019 | NATURE COMMUNICATIONS
Molecular comparison of interval and screen-detected breast cancers
Dane Cheasley, Na Li, Simone M Rowley, Kenneth Elder, G Bruce Mann, Sherene Loi, Peter Savas, David L Goode, Tanjina Kader, Magnus Zethoven, Tim Semple, Stephen B Fox, Jia-Min Pang, David Byrne, Lisa Devereux, Carolyn Nickson, Pietro Procopio, Grant Lee, Siobhan Hughes, Hugo Saunders, et al.
Journal article | 2019 | The Journal of Pathology
Genomic analysis of cancers arising in breasts with different mammographic density
Kylie L Gorringe, Siobhan Hughes, Carolyn Nickson, Lisa Devereux, Vicki Pridmore, Simone M Rowley, David J Byrne, Dane Cheasley, Anne M Kavanagh, G Bruce Mann, Stephen B Fox, Ian G Campbell
Conference Proceedings | 2018 | CANCER RESEARCH
The Sir Peter Maccallum Department Of Oncology